Alzheimer’s disease pathophysiological subtypes and treatment implications


  • Three different Alzheimer’s disease (AD) pathophysiological subtypes were proteomically defined that were associated with distinct biological processes - hyperplasticity, innate immune activation, and blood-brain barrier (BBB) dysfunction – and they may respond differently to different types of treatment.

Why this matters

    Understanding whether subtypes of AD are present and respond differently to different medications will improve treatment outcomes.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.